Avenue Therapeutics, Inc.
ATXI- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001644963
No open-market purchases or sales by Avenue Therapeutics, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Avenue Therapeutics, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 18 | 17 | −1 |
| Shares | 2.36M | 1.04M | −1.32M (−55.9%) |
| Value | $2.14M | $503.0K | −$1.64M (−76.5%) |
New holders (1)
Institutions that held Avenue Therapeutics, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Virtu Financial LLC | 58,004 | $28.0K | 0.00% |
Sold out (2)
Institutions that held Avenue Therapeutics, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Nantahala Capital Management, LLC | 1,453,166 | $1.32M |
| Warberg Asset Management LLC | 10,001 | $9.00K |